Cite
HARVARD Citation
Aglitti, A. et al. (n.d.). Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in HCV infected patients with chronic kidney disease. Digestive and liver disease. pp. e66-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Aglitti, A. et al. (n.d.). Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in HCV infected patients with chronic kidney disease. Digestive and liver disease. pp. e66-. [Online].